Literature DB >> 33895783

Lampaya Medicinalis Phil. decreases lipid-induced triglyceride accumulation and proinflammatory markers in human hepatocytes and fat body of Drosophila melanogaster.

Sofía Sanhueza1,2, Nicolás Tobar3, Mariana Cifuentes2, Daniela Quenti3, Rosaria Varì4, Beatrice Scazzocchio4, Roberta Masella4, Karin Herrera1,2, Adrián Paredes5, Glauco Morales5, Paulina Ormazabal6,7.   

Abstract

BACKGROUND: Excess hepatic triglyceride (TG) accumulation (steatosis) commonly observed in obesity, may lead to non-alcoholic fatty liver disease (NAFLD). Altered regulation of intracellular lipid droplets (LD) and TG metabolism, as well as activation of JNK-mediated proinflammatory pathways may trigger liver steatosis-related disorders. Drosophila melanogaster is an animal model used for studying obesity and its associated disorders. In Drosophila, lipids and glycogen are stored in the fat body (FB), which resembles mammalian adipose tissue and liver. Dietary oversupply leads to obesity-related disorders, which are characterized by FB dysfunction. Infusions of Lampaya medicinalis Phil. (Verbenaceae) are used in folk medicine of Chile to counteract inflammatory diseases. Hydroethanolic extract of lampaya (HEL) contains considerable amounts of flavonoids that may explain its anti-inflammatory effect.
METHODS: We studied whether HEL affects palmitic acid (PA, C16:0) and oleic acid (OA; C18:1)-induced TG accumulation and proinflammatory marker content in HepG2 hepatocytes as well as impaired lipid storage and proinflammatory molecule expression in Drosophila melanogaster fed a high-fat diet (HFD).
RESULTS: In HepG2 hepatocytes, exposure to OA/PA elevated TG content, FABP4, ATGL and DGAT2 expression, and the JNK proinflammatory pathway, as well as TNF-α and IL-6 production, while diminished FAS expression. These effects were prevented by HEL co-treatment. In Drosophila larvae fed a HFD, HEL prevented TG accumulation and downregulated proinflammatory JNK pathway activation.
CONCLUSION: HEL effect counteracting OA/PA- and HFD-induced lipid accumulation and proinflammatory marker expression in HepG2 hepatocytes and Drosophila larvae may represent a preventive approach against hepatic steatosis and inflammation, associated to obesity and NAFLD.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33895783     DOI: 10.1038/s41366-021-00811-8

Source DB:  PubMed          Journal:  Int J Obes (Lond)        ISSN: 0307-0565            Impact factor:   5.095


  39 in total

1.  JNK1 but not JNK2 promotes the development of steatohepatitis in mice.

Authors:  Jörn M Schattenberg; Rajat Singh; Yongjun Wang; Jay H Lefkowitch; Raina M Rigoli; Philipp E Scherer; Mark J Czaja
Journal:  Hepatology       Date:  2006-01       Impact factor: 17.425

2.  Altered fatty acid-binding protein 4 (FABP4) expression and function in human and animal models of hepatocellular carcinoma.

Authors:  Kyle J Thompson; Rebecca Garland Austin; Shayan S Nazari; Keith S Gersin; David A Iannitti; Iain H McKillop
Journal:  Liver Int       Date:  2017-12-22       Impact factor: 5.828

3.  Activation of nuclear factor kappa B and cytokine imbalance in experimental alcoholic liver disease in the rat.

Authors:  A A Nanji; K Jokelainen; A Rahemtulla; L Miao; F Fogt; H Matsumoto; S R Tahan; G L Su
Journal:  Hepatology       Date:  1999-10       Impact factor: 17.425

4.  Lipotoxicity in HepG2 cells triggered by free fatty acids.

Authors:  Hong-Rui Yao; Jun Liu; Daniel Plumeri; Yong-Bing Cao; Ting He; Ling Lin; Yu Li; Yuan-Ying Jiang; Ji Li; Jing Shang
Journal:  Am J Transl Res       Date:  2011-05-10       Impact factor: 4.060

5.  Targeting hepatic TRAF1-ASK1 signaling to improve inflammation, insulin resistance, and hepatic steatosis.

Authors:  Mei Xiang; Pi-Xiao Wang; Ai-Bing Wang; Xiao-Jing Zhang; Yaxing Zhang; Peng Zhang; Fang-Hua Mei; Man-Hua Chen; Hongliang Li
Journal:  J Hepatol       Date:  2016-02-06       Impact factor: 25.083

Review 6.  NF-κB in the liver--linking injury, fibrosis and hepatocellular carcinoma.

Authors:  Tom Luedde; Robert F Schwabe
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-02       Impact factor: 46.802

7.  Hepatic overexpression of hormone-sensitive lipase and adipose triglyceride lipase promotes fatty acid oxidation, stimulates direct release of free fatty acids, and ameliorates steatosis.

Authors:  Brendan N Reid; Gene P Ables; Oleg A Otlivanchik; Gabriele Schoiswohl; Rudolf Zechner; William S Blaner; Ira J Goldberg; Robert F Schwabe; Streamson C Chua; Li-Shin Huang
Journal:  J Biol Chem       Date:  2008-03-12       Impact factor: 5.157

8.  Pharmacological inhibition of adipocyte fatty acid binding protein alleviates both acute liver injury and non-alcoholic steatohepatitis in mice.

Authors:  Ruby L C Hoo; Ida P C Lee; Mi Zhou; Janice Y L Wong; Xiaoyan Hui; Aimin Xu; Karen S L Lam
Journal:  J Hepatol       Date:  2012-10-26       Impact factor: 25.083

9.  Adipocyte fatty acid binding protein levels relate to inflammation and fibrosis in nonalcoholic fatty liver disease.

Authors:  Kerry-Lee Milner; David van der Poorten; Aimin Xu; Elisabetta Bugianesi; James G Kench; Karen S L Lam; Donald J Chisholm; Jacob George
Journal:  Hepatology       Date:  2009-06       Impact factor: 17.425

Review 10.  Thematic review series: glycerolipids. DGAT enzymes and triacylglycerol biosynthesis.

Authors:  Chi-Liang Eric Yen; Scot J Stone; Suneil Koliwad; Charles Harris; Robert V Farese
Journal:  J Lipid Res       Date:  2008-08-29       Impact factor: 5.922

View more
  2 in total

Review 1.  Phenotyping of Drosophila Melanogaster-A Nutritional Perspective.

Authors:  Virginia Eickelberg; Kai Lüersen; Stefanie Staats; Gerald Rimbach
Journal:  Biomolecules       Date:  2022-01-27

Review 2.  Unveiling the Role of the Fatty Acid Binding Protein 4 in the Metabolic-Associated Fatty Liver Disease.

Authors:  Juan Moreno-Vedia; Josefa Girona; Daiana Ibarretxe; Lluís Masana; Ricardo Rodríguez-Calvo
Journal:  Biomedicines       Date:  2022-01-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.